OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Resmetirom Ameliorates NASH-Model Mice by Suppressing STAT3 and NF-κB Signaling Pathways in an RGS5-Dependent Manner
Xiaojing Wang, Liangjing Wang, Lin Geng, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5843-5843
Open Access | Times Cited: 27
Xiaojing Wang, Liangjing Wang, Lin Geng, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5843-5843
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
Thyromimetics and MASLD: Unveiling the Novel Molecules Beyond Resmetirom
Devaraj Ezhilarasan
Journal of Gastroenterology and Hepatology (2025)
Closed Access | Times Cited: 2
Devaraj Ezhilarasan
Journal of Gastroenterology and Hepatology (2025)
Closed Access | Times Cited: 2
Thyroid hormone receptor-beta agonists: new MASLD therapies on the horizon
Christopher D. Byrne, Giovanni Targher, Herbert Tilg
Gut (2024), pp. gutjnl-330596
Open Access | Times Cited: 14
Christopher D. Byrne, Giovanni Targher, Herbert Tilg
Gut (2024), pp. gutjnl-330596
Open Access | Times Cited: 14
Intrahepatic hypothyroidism in MASLD: Role of liver-specific thyromimetics including resmetirom
Mohammad Shafi Kuchay, Scott Isaacs, Anoop Misra
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 5, pp. 103034-103034
Closed Access | Times Cited: 12
Mohammad Shafi Kuchay, Scott Isaacs, Anoop Misra
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 5, pp. 103034-103034
Closed Access | Times Cited: 12
Role of Resmetirom, a Liver-Directed, Thyroid Hormone Receptor Beta-Selective Agonist, in Managing Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis
Deep Dutta, A B Kamrul-Hasan, E Mondal, et al.
Endocrine Practice (2024) Vol. 30, Iss. 7, pp. 631-638
Closed Access | Times Cited: 11
Deep Dutta, A B Kamrul-Hasan, E Mondal, et al.
Endocrine Practice (2024) Vol. 30, Iss. 7, pp. 631-638
Closed Access | Times Cited: 11
Insights on post-translational modifications in fatty liver and fibrosis progression
C. Nageswara Raju, Kavitha Sankaranarayanan
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 3, pp. 167659-167659
Closed Access | Times Cited: 1
C. Nageswara Raju, Kavitha Sankaranarayanan
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 3, pp. 167659-167659
Closed Access | Times Cited: 1
NF-κB signaling is the major inflammatory pathway for inducing insulin resistance
Ahmed Mobeen, Sweta Joshi, Firdaus Fatima, et al.
3 Biotech (2025) Vol. 15, Iss. 2
Closed Access | Times Cited: 1
Ahmed Mobeen, Sweta Joshi, Firdaus Fatima, et al.
3 Biotech (2025) Vol. 15, Iss. 2
Closed Access | Times Cited: 1
Resmetirom and thyroid hormone receptor‐targeted treatment for metabolic dysfunction‐associated steatotic liver disease (MASLD)
Chang‐Hai Liu, Qingchun Zeng, Tianxiao Hu, et al.
Portal hypertension & cirrhosis (2025)
Open Access | Times Cited: 1
Chang‐Hai Liu, Qingchun Zeng, Tianxiao Hu, et al.
Portal hypertension & cirrhosis (2025)
Open Access | Times Cited: 1
Safety and Efficacy of Resmetirom in the treatment of patients with NASH and Liver Fibrosis: A systematic review and meta-analysis
Adarsh Raja, Raja Subhash Sagar, Sadia Saeed, et al.
Annals of Medicine and Surgery (2024)
Open Access | Times Cited: 6
Adarsh Raja, Raja Subhash Sagar, Sadia Saeed, et al.
Annals of Medicine and Surgery (2024)
Open Access | Times Cited: 6
Exploring Varied Treatment Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Amani Elshaer, David M. Chascsa, Blanca Lizaola‐Mayo
Life (2024) Vol. 14, Iss. 7, pp. 844-844
Open Access | Times Cited: 6
Amani Elshaer, David M. Chascsa, Blanca Lizaola‐Mayo
Life (2024) Vol. 14, Iss. 7, pp. 844-844
Open Access | Times Cited: 6
Liver cirrhosis: molecular mechanisms and therapeutic interventions
Zihe Dong, Yeying Wang, Weilin Jin
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 5
Zihe Dong, Yeying Wang, Weilin Jin
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 5
Current Therapeutical Approaches Targeting Lipid Metabolism in NAFLD
Manuela Vitulo, Elisa Gnodi, Giulia Rosini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12748-12748
Open Access | Times Cited: 11
Manuela Vitulo, Elisa Gnodi, Giulia Rosini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12748-12748
Open Access | Times Cited: 11
Exploring Mechanisms of Lang Qing Ata in Non-Alcoholic Steatohepatitis Based on Metabolomics, Network Pharmacological Analysis, and Experimental Validation
Shupei Li, Hanlong Zhu, Qi Zhai, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 1681-1701
Open Access
Shupei Li, Hanlong Zhu, Qi Zhai, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 1681-1701
Open Access
Unlocking the potential of THR-β agonist therapies: resmetirom’s chemistry, biology, and patent insights
K. K. Dahiya, Mahesh B. Palkar, Sanjay Sharma
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
K. K. Dahiya, Mahesh B. Palkar, Sanjay Sharma
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Development of new genipin derivatives as potential NASH treatments: Design, synthesis and action mechanism
Zhuofu Feng, Shiying Fan, Xing-Yu Pan, et al.
Bioorganic Chemistry (2025), pp. 108403-108403
Closed Access
Zhuofu Feng, Shiying Fan, Xing-Yu Pan, et al.
Bioorganic Chemistry (2025), pp. 108403-108403
Closed Access
Inflammation in MASLD Progression and Cancer
Yeon Soo Kim, Y. C. Park, Hyunsoo Rho, et al.
JHEP Reports (2025), pp. 101414-101414
Open Access
Yeon Soo Kim, Y. C. Park, Hyunsoo Rho, et al.
JHEP Reports (2025), pp. 101414-101414
Open Access
Metabolic disorders, inter-organ crosstalk, and inflammation in the progression of metabolic dysfunction-associated steatotic liver disease
Shendong Wang, Junhao Yin, Zhaojun Liu, et al.
Life Sciences (2024) Vol. 359, pp. 123211-123211
Closed Access | Times Cited: 3
Shendong Wang, Junhao Yin, Zhaojun Liu, et al.
Life Sciences (2024) Vol. 359, pp. 123211-123211
Closed Access | Times Cited: 3
Hepatic thyroid hormone receptor‐β signalling: Mechanisms and recent advancements in the treatment of metabolic dysfunction‐associated steatohepatitis
Stergios A. Pοlyzos, Giovanni Targher
Diabetes Obesity and Metabolism (2024)
Closed Access | Times Cited: 2
Stergios A. Pοlyzos, Giovanni Targher
Diabetes Obesity and Metabolism (2024)
Closed Access | Times Cited: 2
Beneficial effects of MGL ‐3196 and BAM15 combination in a mouse model of fatty liver disease
Mingyan Zhou, Catherine Li, Frances L. Byrne, et al.
Acta Physiologica (2024) Vol. 240, Iss. 10
Open Access | Times Cited: 2
Mingyan Zhou, Catherine Li, Frances L. Byrne, et al.
Acta Physiologica (2024) Vol. 240, Iss. 10
Open Access | Times Cited: 2
Actions of thyroid hormones and thyromimetics on the liver
Rohit A. Sinha, Eveline Bruinstroop, Paul M. Yen
Nature Reviews Gastroenterology & Hepatology (2024)
Closed Access | Times Cited: 2
Rohit A. Sinha, Eveline Bruinstroop, Paul M. Yen
Nature Reviews Gastroenterology & Hepatology (2024)
Closed Access | Times Cited: 2
m6A methylation dynamically participates in the immune response against Vibrio anguillarum in half-smooth tongue sole (Cynoglossus semilaevis)
Suxu Tan, Wenwen Wang, Sen Han, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Suxu Tan, Wenwen Wang, Sen Han, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
New advances in drug development for metabolic dysfunction-associated diseases and alcohol-associated liver disease
Jinming Zhang, Yixin Li, Yang Liu, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Jinming Zhang, Yixin Li, Yang Liu, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Lactobacillus delbrueckii subsp. lactis CKDB001 Ameliorates Metabolic Complications in High-Fat Diet-Induced Obese Mice
Hyunsoo Jang, Hyunchae Joung, Jaeryang Chu, et al.
Nutrients (2024) Vol. 16, Iss. 24, pp. 4260-4260
Open Access | Times Cited: 1
Hyunsoo Jang, Hyunchae Joung, Jaeryang Chu, et al.
Nutrients (2024) Vol. 16, Iss. 24, pp. 4260-4260
Open Access | Times Cited: 1
Synthesis and biological evaluation of the novel chrysin prodrug for non-alcoholic fatty liver disease treatment
Ruiming Zhang, Chuanyue Gao, Mingxing Hu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Ruiming Zhang, Chuanyue Gao, Mingxing Hu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Integrating behavioral interventions into a holistic approach to metabolic dysfunction-associated steatotic liver disease
Riccardo Righetti, Felice Cinque, Maria Teresa Volpe, et al.
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 7, pp. 303-313
Closed Access
Riccardo Righetti, Felice Cinque, Maria Teresa Volpe, et al.
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 7, pp. 303-313
Closed Access
